Estrogen promotes prostate cancer cell migration via paracrine release of ENO1 from stromal cells

Molecular Endocrinology

Volumn 26, Issue 9, 2012, Pages 1521-1530

  Yu, Lin ^a,b   Shi, Jiandang ^b   Cheng, Sa ^b   Zhu, Yan ^c   Zhao, Xiulan ^a   Yang, Kuo ^a   Du, Xiaoling ^b   Klocker, Helmut ^d   Yang, Xiaoli ^e   Zhang, Ju ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NANKAI UNIVERSITY   (China)

^c TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ENOLASE; ENOLASE; ENOLASE 1; ESTROGEN; ESTROGEN RECEPTOR ALPHA; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; CANCER CELL; CELL MIGRATION; CONTROLLED STUDY; ENZYME RELEASE; ENZYME STABILITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNODEPLETION ASSAY; IMMUNOHISTOCHEMISTRY; MALE; MASS SPECTROMETRY; PARACRINE SIGNALING; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ELECTROPHORESIS; PROTEIN EXPRESSION; STROMA CELL; TWO DIMENSIONAL ELECTROPHORESIS;

BLOTTING, WESTERN; CULTURE MEDIA, CONDITIONED; DNA-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTROGENS; HUMANS; MALE; PHOSPHOPYRUVATE HYDRATASE; PLASMINOGEN; PROSTATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; STROMAL CELLS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 84865587724     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1006     Document Type: Article

References (35)

1. Prins GS, Korach KS 2008 The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73:233244
2. Ricke WA, McPherson SJ, Bianco JJ, Cunha GR, Wang Y, Ris-bridger GP 2008 Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor a signaling. FASEB J 22:1512-1520
3. Ho SM, Tang WY, Belmonte de Frausto J, Prins GS 2006 Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66:5624-5632
4. Price D, Stein B, Sieber P, Tutrone R, Bailen J, Goluboff E, Burzon D, Bostwick D, Steiner M 2006 Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial. J Urol 176:965-970; discussion 970-971
5. de la Monte SM, Moore GW, Hutchins GM 1986 Metastatic behavior of prostate cancer. Cluster analysis of patterns with respect to estrogen treatment. Cancer 58:985-993
6. Vander Heiden MG, Cantley LC, Thompson CB 2009 Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324:1029-1033
7. Pancholi V 2001 Multifunctional a-enolase: its role in diseases. Cell Mol Life Sci 58:902-920
8. Piast M, Kustrzeba-Wojcicka I, Matusiewicz M, Bana T 2005 Molecular evolution of enolase. Acta Biochim Polonica 52:507513
9. Altenberg B, Greulich KO 2004 Genes of glycolysis are ubiqui-touslyoverexpressedin24 cancer classes. Genomics 84:1014-1020
10. Cappello P, Tomaino B, Chiarle R, Ceruti P, Novarino A, Castag-noli C, Migliorini P, Perconti G, Giallongo A, Milella M, Monsurro V, Barbi S, Scarpa A, Nistico P, Giovarelli M, Novelli F 2009 An integrated humoral and cellular response is elicited in pancreatic cancer by a-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen. Int J Cancer 125:639-648
11. He P, Naka T, Serada S, Fujimoto M, Tanaka T, Hashimoto S, Shima Y, Yamadori T, Suzuki H, Hirashima T, Matsui K, Shiono H, Okumura M, Nishida T, Tachibana I, Norioka N, Norioka S, Kawase I 2007 Proteomics-based identification of a-enolase as a tumor antigen in non-small lung cancer. Cancer Sci 98:1234-1240
12. Seweryn E, Pietkiewicz J, Bednarz-Misa IS, Ceremuga I, Saczko J, Kulbacka J, Gamian A 2009 Localization of enolase in the subfractions of a breast cancer cell line. Z Naturforsch C 64:754-758
13. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF 1991 Role of cell-surface lysines in plasminogen binding to cells: identification of a-enolase as a candidate plasminogen receptor. Biochemistry 30:1682-1691
14. Redlitz A, Fowler BJ, Plow EF, Miles LA 1995 The role of an enolase-related molecule in plasminogen binding to cells. Eur J Biochem 227:407-415
15. Plow EF, FelezJ, Miles LA 1991 Cellular regulation of fibrinolysis. Thromb Haemost 66:32-36
16. Dano K, Behrendt N, Hoyer-Hansen G, Johnsen M, Lund LR, Ploug M, Romer J 2005 Plasminogen activation and cancer. Thromb Haemost 93:676-681
17. Ralhan R, Masui O, Desouza LV, Matta A, Macha M, Siu KW 2011 Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: strategy for discovery of candidate serological biomarkers. Proteomics 11:2363-2376
18. Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y, McCue PA, Quong AA, Lisanti MP, Pestell RG 2010 microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci USA 107:8231-8236
19. Zhang J, Hess MW, Thurnher M, Hobisch A, Radmayr C, Cro-nauer MV, Hittmair A, Culig Z, Bartsch G, Klocker H 1997 Human prostatic smooth muscle cells in culture: estradiol enhances expression of smooth muscle cell-specific markers. Prostate 30: 117-129
20. Feng L, Wang W, Cheng J, Ren Y, Zhao G, Gao C, Tang Y, Liu X, Han W, Peng X, Liu R, Wang L 2007 Genome and proteome of long-chain alkane degrading Geobacillus thermodenitrificans NG80-2 isolated from a deep-subsurface oil reservoir. Proc Natl Acad Sci USA 104:5602-5607
21. Yu L, Wang CY, Shi J, Miao L, Du X, Mayer D, Zhang J 2011 Estrogens promote invasion of prostate cancer cells in a paracrine manner through up-regulation of matrix metalloproteinase 2 in prostatic stromal cells. Endocrinology 152:773-781
22. Zhang Z, Duan L, Du X, Ma H, Park I, Lee C, Zhang J, Shi J 2008 The proliferative effect of estradiol on human prostate stromal cells is mediated through activation of ERK. Prostate 68:508-516
23. Lopez-Alemany R, Longstaff C, Hawley S, Mirshahi M, Fabregas P, Jardi M, Merton E, Miles LA, FelezJ 2003 Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against a-enolase. Am J Hematol 72:234-242
24. van Niel G, Porto-Carreiro I, Simoes S, Raposo G 2006 Exosomes: a common pathway for a specialized function. J Biochem 140: 13-21
25. Wubbolts R, Leckie RS, Veenhuizen PT, Schwarzmann G, Mobius W, Hoernschemeyer J, Slot JW, Geuze HJ, Stoorvogel W 2003 Proteomic and biochemical analyses of human B cell-derived exo-somes. Potential implications for their function and multivesicular body formation. J Biol Chem 278:10963-10972
26. Choi DS, Lee JM, Park GW, Lim HW, Bang JY, Kim YK, Kwon KH, Kwon HJ, Kim KP, Gho YS 2007 Proteomic analysis of microvesicles derived from human colorectal cancer cells. J Proteome Res 6:4646-4655
27. Mathivanan S, Lim JW, Tauro BJ, Ji H, Moritz RL, Simpson RJ 2010 Proteomics analysis of A33 immunoaffinity-purified exo-somes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol Cell Proteomics 9:197-208
28. Mears R, Craven RA, Hanrahan S, Totty N, Upton C, Young SL, Patel P, Selby PJ, Banks RE 2004 Proteomic analysis of melanoma-derived exosomes by two-dimensional polyacrylamide gel electrophoresis and mass spectrometry. Proteomics 4:4019-4031
29. Jansen FH, Krijgsveld J, van Rijswijk A, van den Bemd GJ, van den Berg MS, van Weerden WM, Willemsen R, Dekker LJ, Luider TM, Jenster G 2009 Exosomal secretion of cytoplasmic prostate cancer xenograft-derived proteins. Mol Cell Proteomics 8:1192-1205
30. Hawley SB, Green MA, Miles LA 2000 Discriminating between cell surface and intracellular plasminogen-binding proteins: heteroge neity in profibrinolytic plasminogen-binding proteins on monocy-toid cells. Thromb Haemost 84:882-890
31. Wygrecka M, Marsh LM, Morty RE, Henneke I, Guenther A, Lo-hmeyer J, Markart P, Preissner KT 2009 Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. Blood 113:5588-5598
32. Trojanowicz B, Winkler A, Hammje K, Chen Z, Sekulla C, Glanz D, Schmutzler C, Mentrup B, Hombach-Klonisch S, Klonisch T, Finke R, Kohrle J, Dralle H, Hoang-Vu C 2009 Retinoic acid-mediated down-regulation of ENO1/MBP-1 gene products caused decreased invasiveness of the follicular thyroid carcinoma cell lines. J Mol Endocrinol 42:249-260
33. Valentini A, Biancolella M, Amati F, Gravina P, Miano R, Chillemi G, Farcomeni A, Bueno S, Vespasiani G, Desideri A, Federici G, Novelli G, Bernardini S 2007 Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line. Drug Metab Dispos 35:968-972
34. Nakajima K, Hamanoue M, Takemoto N, Hattori T, Kato K, Koh-saka S 1994 Plasminogen binds specifically to a-enolase on rat neuronal plasma membrane. J Neurochem 63:2048-2057
35. Dudani AK, Cummings C, Hashemi S, Ganz PR 1993 Isolation of a novel 45 kDa plasminogen receptor from human endothelial cells. Thromb Res 69:185-196